SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?


To: The Thrifty Investor who wrote (998)1/3/1999 8:06:00 PM
From: Mark Oliver  Read Replies (1) | Respond to of 1605
 
Can you clarify for me a point. It is my understanding that Vaso makes no money from a treatment. They sell a machine and get a little money on education. If so, where do they really start making big money? It doesn't seem like the basic ailments they are approved to correct will really demand a great number of service centers.

Let's say they sell 500 units in the next 2 years, which would probably be 2 units in every major city. In actual dollars that's not really a lot of money is it? Aren't the cost of these systems less then $50,000?

I'm a bit fuzzy on the whole VASO story. I followed it more closely in the past, but have let it slip off my screen for more important investments. I love the idea of non-invasive health care, but don't see where the profit will come from unless they can get a piece of the patient payments.

Regards,

Mark



To: The Thrifty Investor who wrote (998)1/4/1999 9:11:00 PM
From: Michael Yang  Respond to of 1605
 
Yes, the reimbursement in full or in part may depend on the medicare's decision. But then, it will be a guideline for others to follow. REIMBURSEMENT WILL NOT BE ON CASE BY CASE BASIS. This will help a lot since a patient can decide whether to pitch in the 20 % or not, and this certainly helps them (and the doctors) to make the decision.

Just to make the point, I go to dentists to get my gum done, I need it, and am willing to pay the 20%.